Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Iradimed Corp (IRMD)

Iradimed Corp (IRMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,230,107
  • Shares Outstanding, K 12,783
  • Annual Sales, $ 83,810 K
  • Annual Income, $ 22,480 K
  • EBIT $ 26 M
  • EBITDA $ 27 M
  • 60-Month Beta 1.11
  • Price/Sales 14.72
  • Price/Cash Flow 51.94
  • Price/Book 12.98

Options Overview Details

View History
  • Implied Volatility 42.48% (-2.91%)
  • Historical Volatility 28.56%
  • IV Percentile 71%
  • IV Rank 60.65%
  • IV High 57.32% on 09/11/25
  • IV Low 19.61% on 09/05/25
  • Expected Move (DTE 11) 7.60 (7.90%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 3
  • Volume Avg (30-Day) 23
  • Put/Call OI Ratio 0.60
  • Today's Open Interest 1,054
  • Open Int (30-Day) 1,112
  • Expected Range 88.63 to 103.83

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $0.41
  • Number of Estimates 1
  • High Estimate $0.41
  • Low Estimate $0.41
  • Prior Year $0.37
  • Growth Rate Est. (year over year) +10.81%

Price Performance

See More
Period Period Low Period High Performance
1-Month
93.37 +3.06%
on 04/02/26
107.00 -10.07%
on 03/04/26
-7.51 (-7.24%)
since 03/02/26
3-Month
93.33 +3.11%
on 02/04/26
107.90 -10.82%
on 02/10/26
+0.73 (+0.76%)
since 01/02/26
52-Week
47.48 +102.69%
on 04/09/25
107.90 -10.82%
on 02/10/26
+42.63 (+79.53%)
since 04/02/25

Most Recent Stories

More News
IRADIMED CORPORATION to Participate at the 38th Annual Roth Conference

ORLANDO, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) today announced that it will participate in the  38 th Annual Roth Conference. Iradimed’s CEO, Roger...

IRMD : 96.23 (-0.32%)
IRadimed: Q4 Earnings Snapshot

IRadimed: Q4 Earnings Snapshot

IRMD : 96.23 (-0.32%)
IRADIMED CORPORATION Reports Record Fourth Quarter and Full Year of 2025 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.20 Per Share from $0.17 Per Share

Reports record revenue of $22.7 million for the fourth quarter of 2025, an increase of $3.3 million, or 17%, compared to the same period in 2024. Reports record GAAP diluted EPS of $0.50 and non-GAAP...

IRMD : 96.23 (-0.32%)
IRADIMED CORPORATION to Hold Fourth Quarter and Full Year 2025 Financial Results Conference Call on February 10, 2026

ORLANDO, Fla., Feb. 04, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2025 fourth quarter and full year financial results before the market...

IRMD : 96.23 (-0.32%)
IRADIMED Announces Special Cash Dividend of $0.50 Per Share

ORLANDO, Fla., Dec. 08, 2025 (GLOBE NEWSWIRE) -- iRadimed Corporation (the “Company”) (NASDAQ: IRMD), announced that its Board of Directors (the “Board”) approved a special cash dividend of $0.50...

IRMD : 96.23 (-0.32%)
IRADIMED CORPORATION Named to TIME's List of America's Growth Leaders for 2026

ORLANDO, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in developing innovative magnetic resonance imaging (MRI)-compatible medical devices, today announced its...

IRMD : 96.23 (-0.32%)
IRadimed: Q3 Earnings Snapshot

IRadimed: Q3 Earnings Snapshot

IRMD : 96.23 (-0.32%)
IRADIMED CORPORATION Reports Record Third Quarter 2025 Financial Results

Reports record revenue of $21.2 million for the third quarter of 2025, an increase of $2.9 million, or 16%, compared to the same period in 2024. Reports record GAAP diluted EPS of $0.43 and non-GAAP...

IRMD : 96.23 (-0.32%)
IRADIMED CORPORATION to Hold Third Quarter of 2025 Financial Results Conference Call on November 3, 2025

ORLANDO, Fla., Oct. 27, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2025 third quarter financial results before the market opens on...

IRMD : 96.23 (-0.32%)
IRADIMED CORPORATION Announces Board Transition: Anthony Vuoto Retires, Joe Kiani Appointed as New Director

ORLANDO, Fla., Sept. 02, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (“Iradimed” or the “Company”) (NASDAQ: IRMD), a leader in innovative medical devices for Magnetic Resonance Imaging (“MRI”)-compatible...

IRMD : 96.23 (-0.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

iRadimed Corporation engages in developing, manufacturing, marketing, and distributing magnetic resonance imaging (MRI) compatible products. It offers non-magnetic intravenous (IV) infusion pump systems, IV tubing sets, IV poles, wireless remote displays/controls under the mRidium name; side car pump...

See More

Key Turning Points

3rd Resistance Point 100.54
2nd Resistance Point 98.54
1st Resistance Point 97.38
Last Price 96.23
1st Support Level 94.22
2nd Support Level 92.22
3rd Support Level 91.06

See More

52-Week High 107.90
Last Price 96.23
Fibonacci 61.8% 84.82
Fibonacci 50% 77.69
Fibonacci 38.2% 70.56
52-Week Low 47.48

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.